Jubilant Life Sciences informs about company updates
Date: 25-05-2016Jubilant Life Sciences vide its letter dated May 25, 2016 has informed that the company receives ANDA approval for 0.9% Sodium Chloride Injection USP.
The above information is a part of company’s filings submitted to BSE.